Blood Journal shared a paper Constantine S. Tam and colleagues authored on X:
“Bruton tyrosine kinase inhibitors are an established standard of care in chronic lymphocytic leukemia.”
Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared this post, adding:
“Great review Blood Journal!
Our study on BTK mutations kinase impaired and kinase proficient responding to degraders with Nurix Therapeutics and MSKCC is in the STAT Madness 2025 competition! Read more and vote here.”
Authors: Constantine S. Tam, Shalini Balendran, Piers Blombery
